Bupropion attenuates nicotine abstinence syndrome in the rat

Keywords

Mecamylamine, Bupropion, Nicotine, Abstinence, Nicotine withdrawal

References

• Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic Mechanismden P.J. Boer — 1994
• Nicotine dependence: studies with a laboratory model.David H. Malin — 2001
• Investigating the actions of bupropion on dependence-related effects of nicotine in ratsMohammed Shoaib, Nimish Sidhpura, Sajid Shafait — 2003
• Dramatic decreases in brain reward function during nicotine withdrawalMark P. Epping-Jordan, Shelly S. Watkins, George F. Koob — 1998
• Bupropion: a review of its mechanism of antidepressant activity.John A. Ascher, Jonathan Cole, J. N. Colin — 1995
• Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.John Denis Fryer, Ronald J. Lukas — 1999
• Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.Shelly S. Watkins, Luis Stinus, George F. Koob — 2000
• The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the ratDavid H. Malin, John R. Lake, Merle Shenoi — 1998
• Effect of bupropion on nicotine self-administration in ratsAnthony S. Rauhut, Nicole Neugebauer, Linda P. Dwoskin — 2003
• Nicotine-Induced Changes in Neurotransmitter Levels in Brain Areas Associated with Cognitive FunctionSanford S. Singer, Silvia Rossi, S. Verzosa — 2004
• Effects of antidepressant drugs on rats bred for low activity in the swim test.Charles H.K. West, Jay M. Weiss — 1998
• The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the ratDavid H. Malin, John R. Lake, Victoria Carter — 1994
• Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the ratJohn F. Cryan, Adriaan W. Bruijnzeel, Karen L. Skjei — 2003
• Naloxone precipitates nicotine abstinence syndrome in the ratDavid H. Malin, John R. Lake, Victoria Carter — 1993
• Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal.Michael L. Adams, Theodore J. Cicero — 1998
• Effects of nicotine withdrawal on central dopaminergic systems.Yiu K. Fung, Marian J. Schmid, Todd M. Anderson — 1996
• Smoking, smoking cessation, and major depression.Alexander H. Glassman — 1990
• Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible.David H. Malin — 1996
• Mecamylamine-precipitated nicotine-withdrawal aversion in rats.Tsutomu Suzuki, Yuya Ise, Makoto Tsuda — 1996
• Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence.Suchitra Krishnan‐Sarin, Marc I. Rosen, Stephanie S. O’Malley — 1999

Cited by

• Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus mazeMartin Blawid — 2009
• Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.Yu Ohmura, Emily M. Jutkiewicz, Andrew Zhang — 2011
• Pharmacotherapy for tobacco dependence.Reginald V. Fant, August R. Buchhalter, Albert C. Buchman — 2009
• Bupropion and bupropion analogs as treatments for CNS disorders.F. Ivy Carroll, Bruce E. Blough, S. Wayne Mascarella — 2014
• Neural substrates of psychostimulant withdrawal-induced anhedonia.Manoranjan S. D’Souza, Athina Markou — 2010
• Rodent models of nicotine withdrawal syndrome.David H. Malin, Pilar Goyarzu — 2009
• Efeitos da bupropiona sobre o comportamento sexual, parâmetros espermáticos e fertilidade de ratos machos e sobre a contratilidade do ducto epididimático in vitroMarília Martins Cavariani — 2013
• Identification of Pharmacological and Molecular Mechanisms involved in Nicotine WithdrawalK. Jackson — 2008
• Negative affective states and cognitive impairments in nicotine dependenceF. Scott Hall, Andre Der‐Avakian, Thomas J. Gould — 2015
• PRECLINICAL STUDY: Effects of bupropion, alone or coadministered with nicotine, on social behavior in miceCarmen Gómez, Carmen Carrasco, Rosa Redolat — 2008
• Bupropion treatment increases epididymal contractility and impairs sperm quality with no effects on the epididymal sperm transit time of male ratsMarília Martins Cavariani, Luiz Ricardo de Almeida Kiguti, Josiane de Lima Rosa — 2015
• Pre- and post-nicotine circadian activity episodes are differentially affected by pharmacological treatments for drug addictionAndrea G. Gillman — 2010
• The Role of the Habenula in Nicotine AddictionPhilip R. Baldwin, Raul Alanis, Ramiro Salas — 2011
• Differential Role of Nicotinic Acetylcholine Receptor Subunits in Physical and Affective Nicotine Withdrawal SignsKia J. Jackson, Billy R. Martin, Jean‐Pierre Changeux — 2008
• Effects of oxytocin on nicotine withdrawal in rats.Katherine E. Manbeck, David Shelley, Clare E. Schmidt — 2014
• Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawalVictoria C. Wing, M. Shoaib — 2007
• Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.Robert E. Vann, John A. Rosecrans, John R. James — 2006
• Repetitive Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex Reduces Nicotine Cue CravingXingbao Li, Karen J. Hartwell, Max M. Owens — 2013
• Bupropion Differentially Alters the Aversive, Locomotor and Rewarding Properties of Nicotine in CD-1 MiceAnthony S. Rauhut, Michael Hawrylak, Stacey K. Mardekian — 2008
• Animal models and treatments for addiction and depression co-morbidityNeil E. Paterson, Athina Markou — 2009

Related papers

• Differential Effect of Nicotinic Agonists on the [3H]Norepinephrine Release from Rat Hippocampal SlicesJ. Kiss, Katalin Windisch, Karine De Oliveira Vigier — 2001
• Effects of central nicotinic cholinergic receptor blockade produced by chlorisondamine on learning and memory performance in rats.Michael Decker, Mark J. Majchrzak — 1993
• Modeling the nicotinic receptor loss in dementia using the nicotinic antagonist mecamylamine: Effects on human cognitive functioningPaul Newhouse, Alexandra Potter, June Corwin — 1994
• [3H]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues.Srabani Banerjee, John S. Punzi, Kelley G. Kreilick — 1990
• Evidence for two types of nicotinic receptors in the cat carotid body chemoreceptor cells.Ana Obeso, María Angeles Gómez-Niño, L. Almaraz — 1997
• Nicotinic receptors in mammalian brain.Michael Williams, Janet L. Robinson — 1984
• An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds.Sonja Simpraga, Huibert D. Mansvelder, Geert Jan Groeneveld — 2018